Cargando…
Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine
Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2. Numerous vaccines have been designed and tested in limited clinical trials in various countries. Among them, the Sputnik V vaccine has shown a relatively safe profile and, t...
Autores principales: | Ameri, Maryam, Abolmaali, Meysam, Alwedaie, Sayed Mohammed Jawad, Nabavi, Mohammad, Rahimian, Neda, Hamidabad, Negin Mahmoodi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833308/ https://www.ncbi.nlm.nih.gov/pubmed/35169571 http://dx.doi.org/10.12890/2022_003042 |
Ejemplares similares
-
Mild Facial Paresis in a Recipient of Gam-COVID-Vac Vaccine: A Case
Report
por: Mahmoudi Hamidabad, Negin, et al.
Publicado: (2022) -
Spontaneous Intracranial Hemorrhage: A Sign of Cavernous Angioma Diagnosis in Pediatric Age Group
por: Alwedaie, Sayed Mohammed Jawad, et al.
Publicado: (2021) -
Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review
por: Abolmaali, Meysam, et al.
Publicado: (2022) -
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)